SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
Hong Kong
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Global Bio-chem Technology Group Company Limited (大成生化科技集团有限公司)

Main Activities: Food Manufacturing - Basic Chemical Manufacturing

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Global Bio-chem Technology Group Company Limited (大成生化科技集团有限公司)

Headquarters
Unit 1104, Anmiralty Centre, Tower 1, 18 Harcourt Road, Hong Kong; Hong Kong; Hong Kong
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
ISIN CODE : KYG3919S1057
Financial Auditors: Ernst & Young (2013)
Incorporation Date: May 18, 2000
Total Employees: 6,000

Tel: (852) 2838-8155

Company Description

The Group is involved in the manufacture and sale of corn refined products, corn based sweetener products, corn based biochemical products and biological products.

Company Analysis

According to the Consolidated - Audited financial statement for the first half of 2012, total net operating revenues decreased with -10.59%, from HKD 6,765,253,000 to HKD 6,048,715,000 . The results of the period reached HKD -139,746,000 at the end of the period against HKD 677,095,000 last year. Return on equity (Net income/Total equity) went from 6.31% to -1.20%, the Return On Asset (Net income / Total Asset) went from 3.00% to -0.57% and the Net Profit Margin (Net Income/Net Sales) went from 10.01% to -2.31% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 109.02% compared to 110.40% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 1.41 to 1.45 when compared to the previous year.

Key Executives

LIU Xiaoming Chairman and Executive Director
Xu Ziyi Executive Director
Wang Guifeng Executive Director
LEE Yuen Kwong Independent Non-Exec Director
LI Defa Independent Non-Exec Director
More

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Total Assets

24,360,311

23,750,728

Current Assets

10,421,632

10,497,570

Total Liabilities

12,705,730

11,888,188

Shareholders Equity

11,654,581

11,862,540

Current Liabilities

7,176,657

7,977,732

* All the accounts are in HKD.
Income Statement

Total Operating Revenue

6,048,715

14,438,887

Operational Profit (Loss)

2,104,450

Net Profit (Loss)

-139,746

1,377,972

* All the accounts are in HKD.
Ratios
Profitability Ratios

Return on Assets (ROA)

-0.4%

5.51%

Annualised Return on Assets (ROA)

-1.14%

5.8%

Return on Equity (ROE)

-1.2%

11.62%

Annualised Return on Equity (ROE)

-2.4%

11.62%

Return on Sales (ROS)

-2.31%

9.54%

Return on Capital

-0.81%

8.74%

Gross Profit Margin

14.01%

23.32%

Operating Profit Margin

2.05%

14.48%

Efficiency Ratios

Accounts Receivable Turnover

2.81x

5.74x

Inventory Turnover

1.30x

3.09x

Current asset turnover

0.58x

1.38x

Fixed-asset turnover

0.49x

1.24x

Asset Turnover

0.25x

0.61x

Valuation figures and ratios

Earning Before Interests and Taxes (EBIT)

177,255

2,235,861

EBITDA

-

2,719,767

Enterprise value

12,361,028

13,237,719

Enterprise Value / EBITDA

-

2.97

Bookvalue (BV)

9,623,992

9,796,897

Liquidity Ratios

Current Ratio

145.22%

131.59%

Quick ratio

80.59%

73.09%

Doom's day ratio

28.97%

27.85%

Leverage Ratios

Leverage ratio

209.02%

200.22%

Debt to equity

78.7%

72.72%

Debt to total assets

37.65%

36.32%

Debt / Enterprise Value

74.2%

65.17%

Market ratios

Price/Book Ratio

0

0.43

Trend Ratios

Revenue Trend

89.41%

155.01%

Net Income Trend

-20.64%

368.78%

Operating Income Trend

-13.59%

352.7%